The massive market transformation this month that some on Wall Street called a "once in a decade opportunity" might have just been a one-off technical move because of taxes.Marketsread more
The Pentagon will deploy U.S. forces to the Middle East on the heels of the attack on Saudi Arabian oil facilities, United States Secretary of Defense Mark Esper announced...Defenseread more
CNBC did a deep dive through the most recent Wall Street research to find stocks that analysts say are underappreciated.Marketsread more
Shares of MasterCard are up 46% this year, and 1120% since 2011, getting a boost from the strong U.S. consumer.Investingread more
CNBC sat in on an "empathy training" at Amazon PillPack's Somerville offices, which is part of new hire orientation.Technologyread more
Trade with China is the 'big unknown' for the Federal Reserve as it decides how best to support the U.S. economy, says Council on Foreign Relations Director of International...Futures Nowread more
Lobbying experts said the visit is likely an attempt to be in lawmakers' ears as they consider legislation that would impact Facebook.Technologyread more
Yardeni Research's Edward Yardeni believes the U.S. economy is picking up steam.Trading Nationread more
Iran's audacious drone and cruise missile attack on Saudi Arabia's oil producing facilities has provided a critical test yet for the Trump administration's foreign policy. A...Politicsread more
Chinese trade negotiators suddenly canceled a visit to meet U.S. farmers after they wrapped up trade talks in Washington this week.Marketsread more
The U.S. has to push for sustainable improvements to health care, according to the CEO of Johnson & Johnson.
Congressional Republicans unveiled a broad plan for replacing Obamacare on Mar. 6, which was met with harsh resistance from various factions, including medical service providers who said the bill would probably cause many patients to lose insurance and raise healthcare costs.
For J&J CEO Alex Gorsky, the U.S. saw some "good news" for health care under Barack Obama's presidency and the key will be to make smart revisions going forward, he told CNBC from the China Development Forum in Beijing.
"Whether you take the new plan, the old plan, we are going to have to make changes," he said.
"The challenges are that we still have a lot of other issues to take care of how are we going to make sure that we continue to make some of the important improvements to health care, from a quality, from an affordability and from a sustainability point of view," he said. "And I think that's what we're going to have to work on, to bring forth the next round."
Key focuses will be to keep the number of uninsured Americans low and avoid disadvantaging people with difficult conditions, he said.
Gorsky added that Trump's criticism of the pharmaceutical industry and drug prices, is "much broader than just a pharmaceutical issue."
"Health care or pharmaceuticals only represent about 10 to 15 percent of overall health care spend," he said.
Meanwhile, he said, many of the improvements to life expectancy are due to new treatment drugs.
"What's important is to make sure, obviously, that (pharmaceuticals companies) continue to innovate…that we price responsibly and that we work on some of the reimbursement mechanisms, be it Medicare, Medicaid or through private insurance," he said.